INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2025-10-23 01:29Core Viewpoint - The stock of Yingke Medical (300677) has experienced a decline, with a closing price of 40.71 yuan on October 22, 2025, down 2.28% from the previous day, indicating a trend of net outflow of major funds and mixed retail investor activity [1][2][3]. Financial Performance - Yingke Medical reported a main business revenue of 4.913 billion yuan for the first half of 2025, an increase of 8.9% year-on-year, and a net profit attributable to shareholders of 710 million yuan, up 21.02% year-on-year [5]. - The company's second-quarter revenue was 2.42 billion yuan, reflecting a year-on-year increase of 4.79%, while the net profit for the quarter was 358 million yuan, up 2.55% year-on-year [5]. - The company's gross profit margin stands at 24.23%, which is significantly lower than the industry average of 51.42% [5]. Market Activity - On October 22, 2025, major funds saw a net outflow of 64.62 million yuan, accounting for 9.65% of the total transaction amount, while retail investors had a net inflow of 44.77 million yuan, representing 6.68% of the total [1][2]. - The financing data indicates a net repayment of 7.75 million yuan on October 22, with a total financing balance of 860 million yuan [3]. Industry Comparison - Yingke Medical's total market capitalization is 26.657 billion yuan, significantly higher than the industry average of 11.613 billion yuan, ranking 8th in the industry [5]. - The company has a price-to-earnings ratio of 18.76, which is favorable compared to the industry average of 120.11, ranking 7th [5]. - The return on equity (ROE) for Yingke Medical is 4.03%, outperforming the industry average of 1.91%, ranking 43rd [5].